Elizabeth Read has been appointed chief technology officer of Adicet Bio. Read comes to Menlo Park, CA-based Adicet from Medeor Therapeutics, where she was senior vice president, product development. Her experience also includes management roles at StemCyte, Fate Therapeutics, and the American Red Cross. Pre-clinical stage Adicet is developing cancer immunotherapies.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
